A group representing compounding pharmacies has filed a lawsuit against the US Food and Drug Administration, arguing that the ...
A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
The lawsuit, filed by the Outsourcing Facilities Association , FarmaKeio Custom Compounding and North American Custom Laboratories in the U.S. District Court for the Northern District of Texas, argues ...
ProRx Pharma, the wellness and longevity 503B outsourcing facility, has announced the expansion of its operations to help meet the demand for critical medications?now and into the future with a full ...
Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...
The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...
Hosted on MSN22h
Banned Words at CDC? First Measles Death in Texas Outbreak; House Passes Budget BillCDC staff received an email this week telling them to avoid using more than a dozen terms or words-- including "health equity ...
The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...
An Ohio girl had her dream come true, participating in a father-daughter dance despite being hospitalized while waiting for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback